Abbott Laboratories (ABT) Stock Investment Calculator & Historical Return Analysis

Abbott Laboratories is a global healthcare company that is engaged in the discovery, development, manufacture, and sale of a broad and diversified line of health care products. The company's products include a range of medical devices, diagnostic products, nutritional products and branded generic pharmaceuticals. Investors often view Abbott Laboratories as a key player in the market, analyzing its long-term potential through various revenue models, brand recognition, and consistent presence in its industry.

This Abbott Laboratories stock investment calculator allows you to explore how a hypothetical investment in ABT might have performed over time. By adjusting the investment amount and time period, you can visualize potential growth, compare outcomes across different market cycles, and better understand the impact of long-term investing.

What if you invested $1000 in ABT on Jan 1, 2020?

Explore hypothetical investment results for stocks, ETFs, and more. See real historical data and share your discoveries.

📈
Your investment journey awaits!
Click "Calculate Investment" to see your potential returns
Current Value
$XX,XXX
Return
+XXX%
CAGR
X.XX%
vs SPY
+XX%

Understanding Abbott Laboratories's Historical Performance

Abbott Laboratories's stock performance has historically reflected both broader market trends and company-specific milestones. Like many growth-oriented stocks, ABT has experienced periods of growth driven by innovation and market demand.

When analyzing Abbott Laboratories's historical returns, it's important to consider:

  • Market cycles: Strong bull markets often amplify returns, while recessions can temporarily suppress performance.
  • Business model evolution: Changes in revenue strategies and product lines can significantly impact stability.
  • Long-term trends: Over extended periods, compounding can play a larger role than short-term price fluctuations. Try our calculator to explore returns over 5 years or larger investments over 10 years.

This calculator helps you see how these factors might have affected an investment depending on when you entered the market.

Historical Annual Returns

Over the past 40 years, Abbott Laboratories has delivered an average annual return of 15.8%. The stock peaked in 1991 with a massive +62.4% gain, while investors faced a downturn in 2002 (-26.9%). Overall, the stock finished in the green 32 times out of 40 years.

Avg Return

+15.8%

Win Rate

80%

32W - 8L

Best

+62.4%

1991

Worst

-26.9%

2002

Performance Consistency

32 Positive8 Negative

Abbott Laboratories Annual Returns by Year

YearAnnual ReturnStart PriceEnd Price
1986+36.81%$0.75$1.02
1987+2.81%$1.06$1.09
1988+1.42%$1.10$1.12
1989+45.84%$1.11$1.61
1990+32.79%$1.64$2.18
1991+62.41%$2.10$3.41
1992-7.92%$3.33$3.06
1993+0.02%$3.06$3.06
1994+15.91%$2.99$3.46
1995+29.95%$3.47$4.52
1996+24.18%$4.53$5.62
1997+32.95%$5.58$7.42
1998+47.48%$7.64$11.27
1999-24.41%$11.21$8.48
2000+40.94%$8.17$11.51
2001+17.84%$11.44$13.48
2002-26.85%$13.50$9.88
2003+19.12%$9.89$11.78
2004+17.43%$11.82$13.88
2005-13.52%$13.88$12.01
2006+26.48%$12.04$15.23
2007+17.42%$15.31$17.98
2008-1.89%$17.87$17.53
2009+4.21%$17.60$18.34
2010-9.06%$18.50$16.82
2011+22.01%$16.79$20.48
2012+19.26%$20.66$24.64
2013+21.55%$25.13$30.54
2014+20.40%$30.46$36.68
2015+2.14%$36.58$37.36
2016-8.28%$35.72$32.76
2017+49.54%$33.31$49.81
2018+25.29%$51.31$64.28
2019+27.05%$61.77$78.47
2020+27.91%$78.56$100.48
2021+30.98%$100.13$131.15
2022-19.71%$129.57$104.03
2023+2.46%$103.83$106.38
2024+5.02%$106.17$111.50
2025+12.04%$111.83$125.29

Historical annual returns for Abbott Laboratories. Data shows year-over-year percentage change in stock price.

Why Use a "What If" Stock Calculator?

Many investors wonder questions such as:

A what-if investment calculator answers these questions by turning historical data into practical insights. Rather than focusing on daily price movements, it encourages a long-term perspective, which is especially useful for retirement planning, portfolio comparisons, and financial education.

Key Innovations

  • ✓Pioneered the development of the first HIV blood-screening test.
  • ✓Introduced the first-ever drug-eluting stent to treat coronary artery disease.
  • ✓Developed the FreeStyle Libre, a revolutionary continuous glucose monitoring system.

Business Segments

  • Established Pharmaceutical Products
    This segment includes a broad line of branded generic pharmaceuticals manufactured and marketed and sold outside the United States.
  • Diagnostic Products
    This segment includes a range of diagnostic systems and tests for blood screening, clinical chemistry, and immunodiagnostics.
  • Nutritional Products
    This segment includes a range of adult and pediatric nutritional products.

How to Interpret the Results

The results shown are based on historical performance and are meant for educational and informational purposes only. They do not account for future market conditions, taxes, transaction fees, or individual investment strategies. Past performance does not guarantee future results, but historical analysis can help investors understand risk, volatility, and growth potential.

For best use:

  • Compare multiple time ranges to see how outcomes differ
  • Use consistent assumptions across different stocks
  • Combine this tool with fundamental research and diversification principles

Explore Related Stocks in Tech

Popular in Other Sectors

finance:JPMBACV|healthcare:JNJUNHPFE|consumer:WMTDISNKE|etf:SPYQQQVOO|crypto:BTC-USDETH-USD|